跳至主要内容
临床试验/CTRI/2017/07/009109
CTRI/2017/07/009109尚未招募4 期

A comparative study to see the efficacy of combination of gabapentin and amitryptiline versus amitryptiline alone for the management of chemotherapy induced peripheral neuropathy (CIPN).

ESI Institute of Pain Management ESI Hospital Sealdah0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with cancer having neuropathic pain.
  • 2. Patient on WHO ladder therapy for control of cancer related pain.

排除标准

  • 1. Patients with unstable cardiovascular, respiratory, hepatic or hematological disease or psychological disorder.
  • 2. Patient having diabetes, HIV, Guillain-Barré syndrome, CIDP, radiculopathy.
  • 3. Alchoholic,drug abuse patient.

研究者

发起方
ESI Institute of Pain Management ESI Hospital Sealdah

相似试验